rel-Methyl (3R,4S)-4-(p-tolyl)pyrrolidine-3-carboxylate hydrochloride, 95%, 250mg

Sodium oxazole-2-carboxylate, 95.0%, 250mg

2-(2-fluorophenyl)thiophene, 95%, 250mg

4-Methoxy-2-(trifluoromethoxy)benzyl bromide, 10g

2-Chloro-1-iodo-4-methoxybenzene, 97%, 250mg

4,4,5,5-Tetramethyl-2-phenethyl-1,3,2-dioxaborolane, 95.0%, 10g

3,3'-dithiobis(propionohydrazide), 90%, 5g

N-hydroxy-N-(1-phenylethyl)formamide, 95.0%, 1g

Ethyl 2-ethoxy-1-[[(2'-cyanobiphenyl-4-yl)methyl]benzimidazole]-7-carboxylate, 95.0%, 5g

4-(BOC-AMINO)-N-FMOC-D-PHENYLALANINE, 95%, 250mg

Long working distance plan phase 40x/0.65 IOS objective, working distance 2.74 mm

Tert-butyl(5s)-5-amino-2-oxo-piperidine-1-carboxylate, 98%, 250mg

Closure clips Spectra/Por® with weights, 35 mm, 10 Piece(s)